Lilly to resubmit Cymbalta application

9:33 AM,
Nov. 28, 2008

Written by

Tom Spalding
tom.spalding@indystar.com

Cymbalta, one of the top-selling drugs for Eli Lilly and Co., already is used as a treatment for depression, general anxiety, nerve damage from diabetes and, most recently, for fibromyalgia.

Lilly now sees it potentially aiding people with chronic arthritis-caused knee pain.

The Indianapolis-based drugmaker today said it withdrew an application to FDA to use Cymbalta for a broader range of pains to the knee and back, after regulators questioned whether the drug was shown to work for that purpose. Lilly will update its data and resubmit the application in the first half of 2009, using the ...